Managed by Takeda Pharmaceutical Co Ltd • Latest filing Q3 2025
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | ? N/A — | $111.8M | 6.72M | 0.00% | — |
| 2 | ? N/A — | $107.9M | 6.72M | 0.00% | — |
| 3 | D DNLI — | $97.9M | 4.21M | 0.00% | — |
| 4 | ? N/A — | $97.2M | 6.72M | 0.00% | — |
| 5 |
Overlap peers will appear here as data populates
Related fund suggestions coming soon.
D DNLI — |
| $86.9M |
| 4.21M |
| 0.00% |
| — |
| 6 | D DNLI — | $86.5M | 4.21M | 0.00% | — |
| 7 | P PHAT — | $77.4M | 7.46M | 0.00% | — |
| 8 | P PHAT — | $33.5M | 3.15M | 0.00% | — |
| 9 | O OVID — | $18.5M | 5.75M | 0.00% | — |
| 10 | O OVID — | $17.5M | 5.75M | 0.00% | — |
| 11 | P PHAT — | $16M | 1.56M | 0.00% | — |
| 12 | S STTK — | $14.9M | 2.09M | 0.00% | — |
| 13 | ? N/A — | $13.9M | 6.72M | 0.00% | — |
| 14 | S STTK — | $13.4M | 1.50M | 0.00% | — |
| 15 | ? N/A — | $13.4M | 6.72M | 0.00% | — |
| 16 | ? N/A — | $11.8M | 6.72M | 0.00% | — |
| 17 | ? N/A — | $9.8M | 6.72M | 0.00% | — |
| 18 | W WVE — | $9M | 1.10M | 0.00% | — |
| 19 | O OVID — | $7.5M | 5.75M | 0.00% | — |
| 20 | O OVID — | $6.8M | 5.75M | 0.00% | — |